Abdelkader E. Ashour
Impact in
- Toxicology top 2%
- Bioactive Compounds and Antitumor Agents
-
- Nigella sativa pharmacological applications
Papers in
-
- Enzyme function and inhibition 4
- Immunology 15
- Immunotherapy and Immune Responses 7
- Immune Cell Function and Interaction 5
- Mast cells and histamine 4
- Co-authors
- Sabry M. Attia (21 shared papers)Saleh A. Bakheet (19 shared papers)Khairy M. A. Zoheir (19 shared papers)Sheikh F. Ahmad (18 shared papers)Adel R. A. Abd‐Allah (16 shared papers)Ashok Kumar (15 shared papers)Hesham M. Korashy (8 shared papers)Hala E. Abdel‐Hamied (10 shared papers)
- Journals
- International Immunopharmacology (3 papers)PLoS ONE (3 papers)Molecular and Cellular Biochemistry (2 papers)European Journal of Medicinal Chemistry (2 papers)Immunobiology (2 papers)
- Partner nations
- Saudi ArabiaEgyptUnited States
In The Last Decade
Abdelkader E. Ashour
73 papers receiving 1.8k citations
Peers
Comparison fields: 5 of 117
- Toxicology 80
- Complementary and alternative medicine 150
- Immunology 308
- Pharmaceutical Science 82
- Pharmacology 96
Countries citing papers authored by Abdelkader E. Ashour
This map shows the geographic impact of Abdelkader E. Ashour's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Abdelkader E. Ashour with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Abdelkader E. Ashour more than expected).
Fields of papers citing papers by Abdelkader E. Ashour
This network shows the impact of papers produced by Abdelkader E. Ashour. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Abdelkader E. Ashour. The network helps show where Abdelkader E. Ashour may publish in the future.
Co-authors
The 25 scholars most cited alongside Abdelkader E. Ashour, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 74 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2018 | 105 | |
| 2 | 2015 | 95 | |
| 3 | 2014 | 78 | |
| 4 | 2012 | 67 | |
| 5 | 2014 | 65 | |
| 6 | 2010 | 58 | |
| 7 | 2012 | 55 | |
| 8 | 2014 | 54 | |
| 9 | 2014 | 52 | |
| 10 | 2012 | 52 | |
| 11 | 2013 | 50 | |
| 12 | 2014 | 48 | |
| 13 | 2012 | 48 | |
| 14 | 2007 | 45 | |
| 15 | 2011 | 43 | |
| 16 | 2016 | 41 | |
| 17 | 2015 | 40 | |
| 18 | 2013 | 39 | |
| 19 | 2014 | 38 | |
| 20 | 2022 | 36 |
About Abdelkader E. Ashour
Abdelkader E. Ashour is a scholar working on Molecular Biology, Immunology, Oncology, Organic Chemistry and Cancer Research, having authored 74 papers that have together received 1.9k indexed citations. Recurring topics across this work include Immunotherapy and Immune Responses (7 papers), Quinazolinone synthesis and applications (6 papers), Immune Cell Function and Interaction (5 papers), Enzyme function and inhibition (4 papers), Synthesis and biological activity (4 papers), Mast cells and histamine (4 papers), PARP inhibition in cancer therapy (4 papers) and Chemokine receptors and signaling (4 papers). The work is most often cited by research in Toxicology (80 citations), Complementary and alternative medicine (150 citations), Immunology (308 citations), Pharmaceutical Science (82 citations) and Pharmacology (96 citations). Abdelkader E. Ashour has collaborated with scholars based in Saudi Arabia, Egypt and United States. Frequent co-authors include Sabry M. Attia, Saleh A. Bakheet, Khairy M. A. Zoheir, Sheikh F. Ahmad, Adel R. A. Abd‐Allah, Ashok Kumar, Hesham M. Korashy, Hala E. Abdel‐Hamied, Alaa Eldeen B. Yassin and Mushtaq Ahmad Ansari. Their work appears in journals such as International Immunopharmacology, PLoS ONE, Molecular and Cellular Biochemistry, European Journal of Medicinal Chemistry and Immunobiology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.